CN1311684A - 黄斑变性中新生血管形成的预防治疗 - Google Patents
黄斑变性中新生血管形成的预防治疗 Download PDFInfo
- Publication number
- CN1311684A CN1311684A CN99808257A CN99808257A CN1311684A CN 1311684 A CN1311684 A CN 1311684A CN 99808257 A CN99808257 A CN 99808257A CN 99808257 A CN99808257 A CN 99808257A CN 1311684 A CN1311684 A CN 1311684A
- Authority
- CN
- China
- Prior art keywords
- steroid
- preparation
- compositions
- purposes
- macula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (23)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP4607 | 1998-07-10 | ||
AUPP4607A AUPP460798A0 (en) | 1998-07-10 | 1998-07-10 | Method of treatment |
AUPP5847 | 1998-09-11 | ||
AUPP5847A AUPP584798A0 (en) | 1998-09-11 | 1998-09-11 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1311684A true CN1311684A (zh) | 2001-09-05 |
Family
ID=25645823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99808257A Pending CN1311684A (zh) | 1998-07-10 | 1999-07-12 | 黄斑变性中新生血管形成的预防治疗 |
Country Status (9)
Country | Link |
---|---|
US (1) | US20050124594A1 (zh) |
EP (1) | EP1104302A4 (zh) |
JP (1) | JP2002520287A (zh) |
KR (1) | KR20010071827A (zh) |
CN (1) | CN1311684A (zh) |
CA (1) | CA2336703A1 (zh) |
NO (1) | NO20010114L (zh) |
NZ (1) | NZ509797A (zh) |
WO (1) | WO2000002564A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101142321B (zh) * | 2004-11-18 | 2012-06-06 | 耶鲁大学 | 治疗眼病的方法和组合物 |
CN104193987A (zh) * | 2013-01-21 | 2014-12-10 | 张雅珍 | 一种接枝药物的聚合物的制备和用途 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6726918B1 (en) | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
ES2312456T3 (es) | 2000-08-30 | 2009-03-01 | Johns Hopkins University | Dispositivos para suministro intraocular de farmacos. |
WO2002043785A2 (en) * | 2000-11-29 | 2002-06-06 | Oculex Pharmaceuticals, Inc. | Intraocular implants for preventing transplant rejection in the eye |
EP1621219A3 (en) * | 2000-11-29 | 2006-03-22 | Allergan, Inc. | Intraocular implants for preventing transplant rejection in the eye |
KR20050061586A (ko) * | 2002-10-31 | 2005-06-22 | 셀진 코포레이션 | 황반 변성의 치료를 위한 조성물 |
US20040091455A1 (en) * | 2002-10-31 | 2004-05-13 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
US20050048099A1 (en) | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
WO2005072701A1 (en) | 2004-01-20 | 2005-08-11 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
WO2005072744A1 (ja) * | 2004-02-02 | 2005-08-11 | Yuichi Kaji | 硝子体の可視化剤 |
JP2007520496A (ja) * | 2004-02-04 | 2007-07-26 | レットメッド ピーティーワイ リミテッド | 徐放性ステロイド組成物 |
US20050244469A1 (en) | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Extended therapeutic effect ocular implant treatments |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US20060089590A1 (en) | 2004-10-27 | 2006-04-27 | John Higuchi | Methods and devices for sustained in-vivo release of an active agent |
EP2446888A3 (en) | 2005-07-12 | 2012-08-15 | DMI Biosciences, Inc. | Use of danazol for the treatment of uveitis |
US20070148225A1 (en) * | 2005-12-23 | 2007-06-28 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
US8802128B2 (en) | 2006-06-23 | 2014-08-12 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US9039761B2 (en) | 2006-08-04 | 2015-05-26 | Allergan, Inc. | Ocular implant delivery assemblies with distal caps |
NL1033357C2 (nl) | 2007-02-08 | 2008-08-11 | Arnaldo Goncalves | Inrichting voor het met behulp van een injectie-naald intraoculair toedienen van een substantie, bijvoorbeeld een medicament, in een menselijk of dierlijk oog. |
EP2262506B1 (en) | 2008-03-11 | 2014-05-07 | Alcon Research, Ltd. | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
AU2010264524B2 (en) | 2009-06-22 | 2015-03-19 | Ampio Pharmaceuticals, Inc. | Method for treatment of diseases |
US9827401B2 (en) | 2012-06-01 | 2017-11-28 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US9308355B2 (en) | 2012-06-01 | 2016-04-12 | Surmodies, Inc. | Apparatus and methods for coating medical devices |
JP2016503794A (ja) | 2012-12-19 | 2016-02-08 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 疾患の治療のための方法 |
AU2019207515A1 (en) * | 2018-01-10 | 2020-07-30 | Eye Co Pty Ltd | Medical device and pharmaceutical composition for treatment of an eye disease or condition |
WO2020112816A1 (en) | 2018-11-29 | 2020-06-04 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
US11819590B2 (en) | 2019-05-13 | 2023-11-21 | Surmodics, Inc. | Apparatus and methods for coating medical devices |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1972197A (en) * | 1932-04-20 | 1934-09-04 | William J Mccann | Hand protecting device |
US4131648A (en) * | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
US4180646A (en) * | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
US5088498A (en) * | 1988-10-17 | 1992-02-18 | The Board Of Regents Of The University Of Washington | Ultrasonic plethysmograph |
US4946931A (en) * | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
US5310764A (en) * | 1992-05-08 | 1994-05-10 | Steven Baranowitz | Treatment of age related macular degeneration with beta-carotene |
AU7340694A (en) * | 1993-07-27 | 1995-02-28 | University Of Sydney, The | Treatment of age-related macular degeneration |
WO1995003807A1 (en) * | 1993-07-27 | 1995-02-09 | The University Of Sydney | Treatment of age-related macular degeneration |
US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5968543A (en) * | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
SK284371B6 (sk) * | 1996-02-26 | 2005-02-04 | Advanced Research And Technology Institute | Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva |
AU717283B2 (en) * | 1996-10-30 | 2000-03-23 | Merck & Co., Inc. | Integrin antagonists |
DE19654750A1 (de) * | 1996-12-30 | 1998-07-02 | Helmut Dr Med Zander | Verwendung von Wirkstoffen mit Östrogen-Wirkung zur Vorbeugung und Behandlung von Makuladegeneration |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
JP4859317B2 (ja) * | 1999-08-06 | 2012-01-25 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 薬剤放出生分解性繊維インプラント |
WO2001028472A1 (en) * | 1999-10-21 | 2001-04-26 | Alcon Universal Ltd. | Drug delivery device |
US6395294B1 (en) * | 2000-01-13 | 2002-05-28 | Gholam A. Peyman | Method of visualization of the vitreous during vitrectomy |
JP4787447B2 (ja) * | 2000-01-20 | 2011-10-05 | メルク・シャープ・エンド・ドーム・コーポレイション | αvインテグリン受容体拮抗薬 |
US6866864B2 (en) * | 2000-03-20 | 2005-03-15 | Ahmed Mousa | Compositions and methods of use in the treatment of angiogenesis and vascular-related disorders |
US6613355B2 (en) * | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
US6696426B2 (en) * | 2000-08-22 | 2004-02-24 | Pharmacia Corporation | Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
-
1999
- 1999-07-12 KR KR1020017000395A patent/KR20010071827A/ko not_active Application Discontinuation
- 1999-07-12 EP EP99930939A patent/EP1104302A4/en not_active Withdrawn
- 1999-07-12 CA CA002336703A patent/CA2336703A1/en not_active Abandoned
- 1999-07-12 JP JP2000558823A patent/JP2002520287A/ja active Pending
- 1999-07-12 CN CN99808257A patent/CN1311684A/zh active Pending
- 1999-07-12 NZ NZ509797A patent/NZ509797A/en not_active IP Right Cessation
- 1999-07-12 WO PCT/AU1999/000565 patent/WO2000002564A1/en not_active Application Discontinuation
-
2001
- 2001-01-08 NO NO20010114A patent/NO20010114L/no not_active Application Discontinuation
-
2004
- 2004-10-15 US US10/966,627 patent/US20050124594A1/en not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101142321B (zh) * | 2004-11-18 | 2012-06-06 | 耶鲁大学 | 治疗眼病的方法和组合物 |
CN104193987A (zh) * | 2013-01-21 | 2014-12-10 | 张雅珍 | 一种接枝药物的聚合物的制备和用途 |
Also Published As
Publication number | Publication date |
---|---|
NZ509797A (en) | 2003-11-28 |
NO20010114L (no) | 2001-02-22 |
EP1104302A4 (en) | 2006-08-09 |
JP2002520287A (ja) | 2002-07-09 |
US20050124594A1 (en) | 2005-06-09 |
EP1104302A1 (en) | 2001-06-06 |
CA2336703A1 (en) | 2000-01-20 |
WO2000002564A1 (en) | 2000-01-20 |
KR20010071827A (ko) | 2001-07-31 |
NO20010114D0 (no) | 2001-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1311684A (zh) | 黄斑变性中新生血管形成的预防治疗 | |
US6949518B1 (en) | Methods for treating macular degeneration with topiramate | |
RU2481842C2 (ru) | Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций | |
JPH11512711A (ja) | 身体の内部位置まで薬物を直接供給するための埋め込み可能な放出制御デバイス | |
ES2399976T3 (es) | Uso de profármacos para la administración intravítrea ocular | |
CN110087635A (zh) | 含有作为唯一活性剂的环糊精的眼用组合物 | |
JP2022107631A (ja) | 被験体における虚血再灌流障害のリスクを予防又は軽減するための神経保護特性がある薬物の使用 | |
Robertson et al. | Endogenous Candida oculomycosis: report of two patients treated with flucytosine | |
US6462066B2 (en) | Method and composition for treatment of ischemic neuronal reperfusion injury | |
CN108159051B (zh) | 3-甲基腺嘌呤在制备治疗视网膜下纤维化的药物中的应用 | |
WO2005079792A1 (ja) | 重症糖尿病網膜症の予防又は治療剤 | |
JP2016147890A (ja) | デオキシコール酸およびその塩類の製剤 | |
US20040192699A1 (en) | Optic nerve protecting agents containing alpha1 receptor blocker as active ingredient | |
ES2311592T3 (es) | Remedios para enfermedades de retina y coroides que contienen esteroides como principio activo. | |
Kogure et al. | Efficacy and retention times of intravitreal triamcinolone acetonide for macular edema | |
KR20070061578A (ko) | 눈물 및 침 건조증 치료용 의약 조성물 | |
AU769671B2 (en) | Prophylactic treatments of neovascularisation in macular degeneration | |
RU2824705C1 (ru) | Способ лечения интерстициального цистита с использованием лекарственных композиций | |
RU2820070C2 (ru) | Способ лечения грибкового кератита после сквозной кератопластики | |
CN101365456A (zh) | 治疗原发性和继发性形式的青光眼的方法 | |
JP2007056014A (ja) | ゲル状組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム | |
Dnyanmote Santosh | Study of Intraocular Structures Upon Exposure to Chitosan Membrane Saturated with 5 Fluorouracil Injected Intravitreally in Experimental Settings | |
FRCOPHTH et al. | Management of suspected endophthalmitis in vitrectomized, gas-filled eyes | |
Edema | OZURDEX®(Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion | |
RU2185193C2 (ru) | Способ лечения увеитов у детей |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: WRIGHTMAD PRIVATE LTD. Free format text: FORMER OWNER: THE UNIVERSITY OF SYDNEY Effective date: 20050909 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050909 Address after: Australia Neidelanzi Applicant after: Wright Ahmed Pte Ltd Address before: New South Wales, Australia Applicant before: Univ. of Sydney |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1038195 Country of ref document: HK |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |